Humana Inc (HUM · NYSE)

HUM · MARKET VIEW

Market view · as of Aug 3, 2026

Revenue (TTM)
$145.68B
+26.2% YoY
Gross margin
13.7%
EPS (latest q)
$7.61
vs $6.22 est · beat
52-wk position
81.6%
-11.1% vs 52w high · -8.3% 1mo

Price (last ~year)

Humana Inc. (HUM) has exceeded earnings estimates for four consecutive quarters, most recently reporting $7.61 EPS against a $6.22 estimate for the period ending June 30, 2026. The company generated $145.68 billion in TTM revenue, representing 26.2% year-over-year growth, while operating with a 0.9% profit margin and $14.25 billion in total debt. Shares currently trade at $363.86, reflecting a 52.3% gain over the last three months despite an 8.3% decline in the past month.

Valuation

Market cap
$43.69B
P/E
34.36
PEG
2.061
P/B
2.274
P/S
0.3
Beta
0.717
Analyst target
$407.83

Quality & returns

Gross margin
13.7%
Operating margin
3.5%
Profit margin
0.9%
ROE
6.9%
ROA
3.9%

Price movement

Last
$363.86
1-month
-8.3%
3-month
+52.3%
RSI (14)
29
vs SMA200
+37.9%
52-wk position
81.6% -11.1% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$40.87B$1.36B$693.0M$1.31B
2026-03-31$39.65B$1.58B$1.19B$1.97B
2025-12-31$32.52B$-1.02B$-796.0M$-685.0M
2025-09-30$32.65B$108.0M$195.0M$480.0M

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots